Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from AEVIS VICTORIA SA ( (CH:AEVS) ) is now available.
MRH Switzerland AG, a subsidiary of AEVIS VICTORIA SA, reported a 3.7% increase in turnover to CHF 103.9 million in the first half of 2025, driven by organic growth. The company’s EBITDAR improved, reflecting strong demand in the premium segment and effective cost management. Key hotels exceeded expectations, highlighting the success of its flagship strategy. The company plans to continue investing in operational excellence to sustain value creation.
The most recent analyst rating on (CH:AEVS) stock is a Hold with a CHF15.00 price target. To see the full list of analyst forecasts on AEVIS VICTORIA SA stock, see the CH:AEVS Stock Forecast page.
More about AEVIS VICTORIA SA
AEVIS VICTORIA SA is a diversified investment company focusing on Healthcare, Lifestyle, and Infrastructure. Its main holdings include Swiss Medical Network Holding SA, the only private clinic group in Switzerland with a presence in all three language regions; MRH Switzerland AG, a hotel chain; Infracore SA, specializing in hospital and healthcare infrastructure; Swiss Hotel Properties AG, focusing on hotel infrastructure; and NESCENS SA, a brand for prevention and better-aging.
Average Trading Volume: 13,127
Technical Sentiment Signal: Sell
Current Market Cap: CHF1.13B
See more data about AEVS stock on TipRanks’ Stock Analysis page.